Abstract
Aim: Previous studies that investigated the effect of green tea/green tea extract on anthropometric indices among type 2 diabetes mellitus (T2DM) patients found inconsistent results. Thus, in order to clarify the efficacy of green tea supplementation on anthropometric indices and body composition, we conducted a systematic review and meta-analysis to sum up the evidence of randomized controlled trials. Methods: A systematic search was conducted in the Scopus, ISI Web of Science and PubMed to find the related articles, up to June 2019. Meta-analysis was performed using the random effects model, and the I2 index was used to evaluate the heterogeneity. Results: Eleven articles were eligible. Our meta-analysis indicated that green tea consumption significantly decreased body weight, body mass index (BMI), and body fat (BF). The beneficial effect of green tea intake was observed in long-term intervention (>8 weeks), at lower doses of green tea (dosage ≤800 mg/day), and in overweight patients. Conclusion: This study revealed the beneficial effects of green tea consumption in reducing body weight, BMI, and BF in T2DM patients. It should be noted that green tea was effective in long-term intervention, at lower doses of green tea, and in overweight patients.
References
1.
Wild
S
, Roglic
G
, Green
A
, Sicree
R
, King
H
. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030
. Diabetes Care
. 2004
May
;27
(5
):1047
–53
.
[PubMed]
0149-59922.
Qi
L
, Hu
FB
, Hu
G
. Genes, environment, and interactions in prevention of type 2 diabetes: a focus on physical activity and lifestyle changes
. Curr Mol Med
. 2008
Sep
;8
(6
):519
–32
.
[PubMed]
1566-52403.
Nahas
R
, Moher
M
. Complementary and alternative medicine for the treatment of type 2 diabetes
. Can Fam Physician
. 2009
Jun
;55
(6
):591
–6
.
[PubMed]
1715-52584.
Diepvens
K
, Westerterp
KR
, Westerterp-Plantenga
MS
. Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea
. Am J Physiol Regul Integr Comp Physiol
. 2007
Jan
;292
(1
):R77
–85
.
[PubMed]
0363-61195.
Legeay
S
, Rodier
M
, Fillon
L
, Faure
S
, Clere
N
. Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome
. Nutrients
. 2015
Jul
;7
(7
):5443
–68
.
[PubMed]
2072-66436.
Alipour
M
, Malihi
R
, Hosseini
SA
, Abbasnezhad
A
, Ghavami
A
, Shahmohammadi
HA
, et al. The effects of catechins on related risk factors with Type 2 diabetes: a review
. Prog Nutr
. 2018
;20
:12
–20
.1129-87237.
Nagao
T
, Hase
T
, Tokimitsu
I
. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans
. Obesity (Silver Spring)
. 2007
Jun
;15
(6
):1473
–83
.
[PubMed]
1930-73818.
Tsuchida11 T, Itakura21 H. Reduction of body fat in humans by long-term ingestion of catechins
. Prog Med.
2002
;22
:2189
–203
.9.
Matsumoto
N
, Ishigaki
F
, Ishigaki
A
, Iwashina
H
, Hara
Y
. Reduction of blood glucose levels by tea catechin
. Biosci Biotechnol Biochem
. 1993
;57
(4
):525
–7
. 0916-845110.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
, Group
P
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
2010
. Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. 2008. 11.
Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Chichester: Wiley & Sons; 2008.
12.
DerSimonian
R
, Kacker
R
. Random-effects model for meta-analysis of clinical trials: an update
. Contemp Clin Trials
. 2007
Feb
;28
(2
):105
–14
.
[PubMed]
1551-714413.
Hozo
SP
, Djulbegovic
B
, Hozo
I
. Estimating the mean and variance from the median, range, and the size of a sample
. BMC Med Res Methodol
. 2005
Apr
;5
(1
):13
.
[PubMed]
1471-228814.
Fukino
Y
, Shimbo
M
, Aoki
N
, Okubo
T
, Iso
H
. Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers
. J Nutr Sci Vitaminol (Tokyo)
. 2005
Oct
;51
(5
):335
–42
.
[PubMed]
0301-480015.
Fukino
Y
, Ikeda
A
, Maruyama
K
, Aoki
N
, Okubo
T
, Iso
H
. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities
. Eur J Clin Nutr
. 2008
Aug
;62
(8
):953
–60
.
[PubMed]
0954-300716.
Mirzaei
K
, Hossein-Nezhad
A
, Karimi
M
, Hosseinzadeh-Attar
MJ
, Jafari
N
, Najmafshar
A
, et al. Effect of green tea extract on bone turnover markers in type 2 diabetic patients; A double-blind, placebo-controlled clinical trial study
. Daru
. 2009
;17
:38
–44
.1560-811517.
Nagao
T
, Meguro
S
, Hase
T
, Otsuka
K
, Komikado
M
, Tokimitsu
I
, et al. A catechin-rich beverage improves obesity and blood glucose control in patients with type 2 diabetes
. Obesity (Silver Spring)
. 2009
Feb
;17
(2
):310
–7
.
[PubMed]
1930-738118.
Mohammadi
S
, Hosseinzadeh Attar
MJ
, Karimi
M
, Hosseinnezhad
A
, Eshraghian
MR
, Hosseini
SH
, et al. The effects of green tea extract on serum adiponectin concentration and insulin resistance in patients with type 2 diabetes mellitus
. Journal of Zanjan University of Medical Sciences and Health Services.
2010
;18
:44
–57
.19.
Hsu
CH
, Liao
YL
, Lin
SC
, Tsai
TH
, Huang
CJ
, Chou
P
. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebo-controlled clinical trial
. Altern Med Rev
. 2011
Jun
;16
(2
):157
–63
.
[PubMed]
1089-515920.
Mousavi
A
, Vafa
M
, Neyestani
T
, Khamseh
M
, Hoseini
F
. The effects of green tea consumption on metabolic and anthropometric indices in patients with Type 2 diabetes
. J Res Med Sci
. 2013
Dec
;18
(12
):1080
–6
.
[PubMed]
1735-199521.
Liu
CY
, Huang
CJ
, Huang
LH
, Chen
IJ
, Chiu
JP
, Hsu
CH
. Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial
. PLoS One
. 2014
Mar
;9
(3
):e91163
.
[PubMed]
1932-620322.
Borges
CM
, Papadimitriou
A
, Duarte
DA
, Lopes de Faria
JM
, Lopes de Faria
JB
. The use of green tea polyphenols for treating residual albuminuria in diabetic nephropathy: A double-blind randomised clinical trial
. Sci Rep
. 2016
Jun
;6
(1
):28282
.
[PubMed]
2045-232223.
Zandi Dareh Gharibi
Z
, Faramarzi
M
, Banitalebi
E
. The effect of rhythmic aerobic exercise and green tea supplementation on visfatin levels and metabolic risk factors in obese diabetic women
. Faslnamah-i Giyahan-i Daruyi
. 2018
;17
:145
–56
.1684-024024.
Quezada-Fernández
P
, Trujillo-Quiros
J
, Pascoe-González
S
, Trujillo-Rangel
WA
, Cardona-Müller
D
, Ramos-Becerra
CG
, et al. Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial
. Int J Food Sci Nutr
. 2019
Dec
;70
(8
):977
–85
.
[PubMed]
0963-748625.
Gupta
D
, Krueger
CB
, Lastra
G
. Over-nutrition, obesity and insulin resistance in the development of β-cell dysfunction
. Curr Diabetes Rev
. 2012
Mar
;8
(2
):76
–83
.
[PubMed]
1573-399826.
Franz
MJ
, Boucher
JL
, Rutten-Ramos
S
, VanWormer
JJ
. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials
. J Acad Nutr Diet
. 2015
Sep
;115
(9
):1447
–63
.
[PubMed]
2212-267227.
Hasumura
T
, Shimada
Y
, Kuroyanagi
J
, Nishimura
Y
, Meguro
S
, Takema
Y
, et al. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish
. Nutr Metab (Lond)
. 2012
Aug
;9
(1
):73
.
[PubMed]
1743-707528.
Li
X
, Wang
W
, Hou
L
, Wu
H
, Wu
Y
, Xu
R
, et al. Does tea extract supplementation benefit metabolic syndrome and obesity? A systematic review and meta-analysis
. Clin Nutr
. 2019
.
[PubMed]
0261-561429.
Hibi
M
, Takase
H
, Iwasaki
M
, Osaki
N
, Katsuragi
Y
. Efficacy of tea catechin-rich beverages to reduce abdominal adiposity and metabolic syndrome risks in obese and overweight subjects: a pooled analysis of 6 human trials
. Nutr Res
. 2018
Jul
;55
:1
–10
.
[PubMed]
0271-531730.
Hursel
R
, Viechtbauer
W
, Westerterp-Plantenga
MS
. The effects of green tea on weight loss and weight maintenance: a meta-analysis
. Int J Obes
. 2009
Sep
;33
(9
):956
–61
.
[PubMed]
0307-056531.
TAKASE H. Effect of Long-term Ingestion of Tea Catechins on Visceral Fat Accumulation and Metabolic Syndrome
. Jpn Pharmacol Ther
. 2008
;36
:509
–14
.32.
Yang
CS
, Zhang
J
, Zhang
L
, Huang
J
, Wang
Y
. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea
. Mol Nutr Food Res
. 2016
Jan
;60
(1
):160
–74
.
[PubMed]
1613-412533.
Yamashita
Y
, Wang
L
, Wang
L
, Tanaka
Y
, Zhang
T
, Ashida
H
. Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase
. Food Funct
. 2014
Oct
;5
(10
):2420
–9
.
[PubMed]
2042-649634.
Suzuki
T
, Pervin
M
, Goto
S
, Isemura
M
, Nakamura
Y
. Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity
. Molecules
. 2016
Sep
;21
(10
):1305
.
[PubMed]
1420-304935.
Abbaszadeh
A
, Darabi
S
, Hasanvand
A
, Amini-Khoei
H
, Abbasnezhad
A
, Choghakhori
R
, et al. Minocycline through attenuation of oxidative stress and inflammatory response reduces the neuropathic pain in a rat model of chronic constriction injury
. Iran J Basic Med Sci
. 2018
Feb
;21
(2
):138
–44
.
[PubMed]
2008-386636.
Suzuki
Y
, Miyoshi
N
, Isemura
M
. Health-promoting effects of green tea
. Proc Jpn Acad, Ser B, Phys Biol Sci
. 2012
;88
(3
):88
–101
.
[PubMed]
0386-220837.
Asbaghi
O
, Fouladvand
F
, Gonzalez
MJ
, Aghamohammadi
V
, Choghakhori
R
, Abbasnezhad
A
. The effect of green tea on C-reactive protein and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: A systematic review and meta-analysis
. Complement Ther Med
. 2019
Oct
;46
:210
–6
.
[PubMed]
0965-229938.
Amani
R
, Abbasnezhad
A
, Hajiani
E
, Cheraghian
B
, Abdoli
Z
, Choghakhori
R
. Vitamin D3 Induced Decrease in IL-17 and Malondialdehyde, and Increase in IL-10 and Total Antioxidant Capacity Levels in Patients with Irritable Bowel Syndrome
. Iran J Immunol
. 2018
Sep
;15
(3
):186
–96
.
[PubMed]
1735-367X39.
Astrup
A
, Toubro
S
, Cannon
S
, Hein
P
, Breum
L
, Madsen
J
. Caffeine: a double-blind, placebo-controlled study of its thermogenic, metabolic, and cardiovascular effects in healthy volunteers
. Am J Clin Nutr
. 1990
May
;51
(5
):759
–67
.
[PubMed]
0002-916540.
Astrup
A
, Breum
L
, Toubro
S
, Hein
P
, Quaade
F
. The effect and safety of an ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on an energy restricted diet. A double blind trial. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1992
;16:269-77.41.
Dulloo
AG
, Geissler
CA
, Horton
T
, Collins
A
, Miller
DS
. Normal caffeine consumption: influence on thermogenesis and daily energy expenditure in lean and postobese human volunteers
. Am J Clin Nutr
. 1989
Jan
;49
(1
):44
–50
.
[PubMed]
0002-916542.
Chan
CC
, Koo
MW
, Ng
EH
, Tang
OS
, Yeung
WS
, Ho
PC
. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome—a randomized placebo-controlled trial
. J Soc Gynecol Investig
. 2006
Jan
;13
(1
):63
–8
.
[PubMed]
1071-557643.
Takeshita
M
, Takashima
S
, Harada
U
, Shibata
E
, Hosoya
N
, Takase
H
, et al. Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans
. Jpn Pharmacol Ther
. 2008
;36
:767
–76
.© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
